Andrew Gengos

Insider Reports History

Location
Bothell, WA
Signature
/s/ David Strauss, as Attorney-in-Fact for Andrew Gengos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Gengos:

Company Role Class Num Shares Value Price $ Report Date Ownership
Terns Pharmaceuticals, Inc. Chief Financial Officer Common Stock 101,788 $4,112,235 $40.40 14 Jan 2026 Direct
Cyteir Therapeutics, Inc. Chief Business Officer Common Stock 73,534 $124,272 $1.69 17 Jun 2021 Direct
Athira Pharma, Inc. CFO and Chief Business Officer Common Stock 97,532 $55,203 $0.5660 05 Sep 2024 Direct
Athira Pharma, Inc. CFO and Chief Business Officer Stock Option (Right to Buy) 280,000 14 Feb 2024 Direct
Terns Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 137,500 14 Jan 2026 Direct
Cyteir Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 35,000 22 Feb 2022 Direct
Global Health Solutions, Inc Director Common Stock 10,000 08 Oct 2025 Direct

Insider Reports Filed by Andrew Gengos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TERN Terns Pharmaceuticals, Inc. 14 Jan 2026 2 $0 4 Chief Financial Officer 16 Jan 2026, 17:23
TTRX Turn Therapeutics Inc. 08 Oct 2025 1 $0 4 Director 10 Oct 2025, 09:40
TTRX Turn Therapeutics Inc. 07 Oct 2025 0 $0 3 Director 07 Oct 2025, 19:02
TERN Terns Pharmaceuticals, Inc. 27 Jun 2025 2 +$39,283 4 Chief Financial Officer 30 Jun 2025, 17:38
TERN Terns Pharmaceuticals, Inc. 13 Jun 2025 3 +$57,082 4 Chief Financial Officer 16 Jun 2025, 18:05
TERN Terns Pharmaceuticals, Inc. 24 Feb 2025 1 $0 4 Chief Financial Officer 25 Feb 2025, 18:12
TERN Terns Pharmaceuticals, Inc. 24 Feb 2025 0 $0 3 Chief Financial Officer 25 Feb 2025, 18:10
ATHA Athira Pharma, Inc. 03 Sep 2024 3 +$12,680 4 CFO and Chief Business Officer 05 Sep 2024, 19:51
ATHA Athira Pharma, Inc. 14 Feb 2024 1 $0 4 CFO AND CHIEF BUSINESS OFFICER 16 Feb 2024, 16:48
ATHA Athira Pharma, Inc. 04 Jan 2024 2 -$3,515 4/A CFO AND CHIEF BUSINESS OFFICER 16 Feb 2024, 16:34
ATHA Athira Pharma, Inc. 04 Jan 2024 2 -$3,515 4 Officer 08 Jan 2024, 16:42
ATHA Athira Pharma, Inc. 07 Jun 2023 3 +$51,445 4 Officer 09 Jun 2023, 17:06
ATHA Athira Pharma, Inc. 02 Jun 2023 7 +$191,572 4 Officer 06 Jun 2023, 19:36
ATHA Athira Pharma, Inc. 18 May 2023 1 $0 4 Officer 22 May 2023, 17:53
ATHA Athira Pharma, Inc. 18 May 2023 0 $0 3 Officer 22 May 2023, 17:51
/report/000089924322007638-gengos-andrew-2022-02-22 Cyteir Therapeutics, Inc. 22 Feb 2022 1 $0 4 Chief Business Officer 24 Feb 2022, 15:57
/report/000089924321024574-gengos-andrew-2021-06-17 Cyteir Therapeutics, Inc. 17 Jun 2021 0 $0 3 Chief Business Officer 17 Jun 2021, 21:15